Covered recipient · General Payments record
GEORGE KATSAMAKIS
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$209,814.12
- Reported across 657 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,297.00 | 1 |
| Food and Beverage | $2,800.24 | 108 |
| Consulting Fee | $2,780.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Ares Trading SA | $7,297.00 | 1 |
| EMD Serono, Inc. | $3,354.22 | 11 |
| TG THERAPEUTICS, INC. | $352.02 | 15 |
| ABBVIE INC. | $228.03 | 13 |
| PFIZER INC. | $199.50 | 12 |
| Biogen, Inc. | $184.82 | 8 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $177.41 | 14 |
| Celgene Corporation | $169.80 | 6 |
| Inspire Medical Systems, Inc. | $160.62 | 1 |
| Amgen Inc. | $110.25 | 5 |
| Genentech USA, Inc. | $97.77 | 4 |
| Lilly USA, LLC | $86.88 | 3 |
| Lundbeck LLC | $74.76 | 3 |
| UCB, Inc. | $64.65 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $48.86 | 2 |
| EISAI INC. | $43.60 | 2 |
| MDD US Operations, LLC | $38.81 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $35.57 | 1 |
| Merz Pharmaceuticals, LLC | $31.95 | 1 |
| Alexion Pharmaceuticals, Inc. | $31.21 | 1 |
| Teva Pharmaceuticals USA, Inc. | $29.46 | 1 |
| ARGENX US, INC. | $21.06 | 1 |
| Abbott Laboratories | $20.66 | 1 |
| Amylyx Pharmaceuticals, Inc. | $18.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (110)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.